Lv1
36 积分 2025-01-25 加入
DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions
5天前
已完结
Insights into CYP450 polymorphisms and their impact on drug metabolism in Alzheimer’s disease therapy
15天前
已完结
Development and validation of a quick and sensitive UPLC-MS/MS method for measuring ensartinib in HLMs: investigation of structural alerts associated with metabolic lability and in silico toxicity
1个月前
已完结
LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib
1个月前
已完结
Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes
1个月前
已完结
Drug-induced enzyme activity inhibition and CYP3A4 genetic polymorphism significantly shape the metabolic characteristics of furmonertinib
4个月前
已完结
Befotertinib: First Approval
4个月前
已完结
Validation of population pharmacokinetic models: a comparison of internal and external validation approaches for hydrochlorothiazide
4个月前
已完结
THE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGS
5个月前
已完结
Effects of Cytochrome P450 enzymes and drug–drug interaction on donafenib metabolism: in vivo, in vitro and in silico
5个月前
已完结